Ridgefield Acquisition Corp. CEO Files 13D/A Amendment
Ticker: RDGAD · Form: SC 13D/A · Filed: Apr 29, 2024 · CIK: 812152
| Field | Detail |
|---|---|
| Company | Ridgefield Acquisition Corp (RDGAD) |
| Form Type | SC 13D/A |
| Filed Date | Apr 29, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $0.002, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, ownership-change, amendment
TL;DR
Ridgefield Acquisition Corp. CEO Bronson filed a 13D/A amendment, updating ownership details for the blank check company.
AI Summary
Steven N. Bronson, CEO of Ridgefield Acquisition Corp., filed an amendment (Amendment No. 24) to Schedule 13D on April 23, 2024. The filing relates to the common stock of Ridgefield Acquisition Corp. and provides updated information regarding beneficial ownership. The company was formerly known as Bio Medical Automation Inc. and Ozo Diversified Automation Inc.
Why It Matters
This filing updates the ownership structure and potentially signals changes in control or strategy for Ridgefield Acquisition Corp., a blank check company.
Risk Assessment
Risk Level: medium — Schedule 13D filings, especially amendments, can indicate significant changes in a company's ownership or strategic direction, which may carry inherent risks.
Key Players & Entities
- Steven N. Bronson (person) — CEO and person authorized to receive notices
- Ridgefield Acquisition Corp. (company) — Subject Company
- Bio Medical Automation Inc. (company) — Former Company Name
- Ozo Diversified Automation Inc. (company) — Former Company Name
- SB4 INVESTMENTS LLC (company) — Group Member
FAQ
What is the primary purpose of this SC 13D/A filing?
This filing is an amendment (Amendment No. 24) to Schedule 13D, used to update information regarding beneficial ownership of Ridgefield Acquisition Corp.'s common stock.
Who is the principal executive officer of Ridgefield Acquisition Corp. and what is their role in this filing?
Steven N. Bronson is the Chief Executive Officer and is listed as the person authorized to receive notices and communications regarding this filing.
When was this amendment filed with the SEC?
This amendment was filed on April 29, 2024, with the date of the event (date of change) also being April 29, 2024.
What were the previous names of Ridgefield Acquisition Corp.?
Ridgefield Acquisition Corp. was formerly known as Bio Medical Automation Inc. (name change on March 23, 1999) and Ozo Diversified Automation Inc. /CO/ (name change on July 3, 1992).
What is the business address listed for Ridgefield Acquisition Corp.?
The business address is 3827 S Carson St, Unit 505-25, PMB 1078, Carson City, NV 89701.
Filing Stats: 1,839 words · 7 min read · ~6 pages · Grade level 9.4 · Accepted 2024-04-29 16:05:20
Key Financial Figures
- $0.001 — e of Issuer ) Common Stock, par value $0.001 per share (Title of Class of Securitie
- $0.002 — of Common Stock at a purchase price of $0.002 per share, for an aggregate purchase pr
- $50,000 — are, for an aggregate purchase price of $50,000. Mr. Bronson paid the purchase price in
Filing Documents
- tm2412895d1_sc13da.htm (SC 13D/A) — 63KB
- tm2412895d1_ex99-1.htm (EX-99.1) — 3KB
- 0001104659-24-054001.txt ( ) — 68KB
Contracts, Arrangements, Understandings or Relationships
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. On July 1, 2022, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to securities of the Issuer, to the extent required by applicable law. A copy of this agreement is attached as an exhibit hereto and is incorporated herein by reference. Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer. Item 7. Material to be Filed as Exhibits. Exhibit No. Description 99.1 Joint Filing Agreement by and among SB4 Investments LLC and Steven N. Bronson, dated July 1, 2022. 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: April 26, 2024 SB4 INVESTMENTS LLC By: /s/ Steven N. Bronson Name: Steven N. Bronson Title: Manager Date: April 26, 2024 /s/ Steven N. Bronson Steven N. Bronson 7